PURPOSE: A composition for a medicine food or a beverage is provided to prevent telangiectasia on the face neck hands and/or shoulders of a consumer by comprising a H2 histamine receptor antagonist. CONSTITUTION: A composition for a medicine for suppressing telangiectasia due to alcohol consumption comprises cimetidine and a carrier which is pharmaceutically acceptable. The composition is injected 2-60 minutes before alcohol consumption. The composition for food or a beverage for suppressing tel...

The present invention provides improved systems and methods for the local delivery of H2 antagonists. The inventive methods include topical administration of an effective amount of a H2 antagonist encapsulated in liposomes. In certain embodiments, the H2 antagonist, for example, Cimetidine, is encapsulated into paucilamellar liposomes, such as NOVASOME TM microvesicles. Also provided are pharmaceutical compositions comprising liposome-encapsulated H2 antagonists. The methods and compositions of...

The present invention provides improved systems and methods for the local delivery of H2 antagonists. The inventive methods include topical administration of an effective amount of a H2 antagonist encapsulated in liposomes. In certain embodiments the H2 antagonist for example Cimetidine is encapsulated into paucilamellar liposomes such as NOVASOME® microvesicles. Also provided are pharmaceutical compositions comprising liposome-encapsulated H2 antagonists. The methods and compositions of the pre...